Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: transdermal

June 1, 2026 Drug delivery / Pharma applications

Biphasic dissolving microneedles with cyclodextrin inclusion complexes for enhanced delivery of poorly soluble drugs

Dissolving microneedles (DMNs) have been widely investigated for transdermal drug delivery, yet their clinical translation and commercialization remain limited, primarily

Continue reading

August 21, 2024 Drug delivery / Pharma applications

Risperidone-cyclodextrin complex reservoir combined with hydrogelforming microneedle array patches for enhanced transdermal delivery

Hydrogel-forming microneedle array patches (HFMAPs) are microneedles that create microconduits upon insertion and swelling in the skin, potentially allowing prolonged

Continue reading

October 30, 2023 Life sciences

Cyclodextrin enabled transdermal peptide delivery by cyclodextrin

Non invasive peptide delivery is a highly needed, especially challenging discipline. Auro Wellness has developed a transdermally absorbed glutathione (GSH)

Continue reading

January 10, 2023 Drug delivery / Pharma applications

Transdermal delivery by smart tattoo

Tattoos are already used in the clinic to mark where doctors will apply radiation treatments, to correct skin discoloration, to mark

Continue reading

August 17, 2020 Drug delivery / Pharma applications

Biodegradable β ‐Cyclodextrin Conjugated Gelatin Methacryloyl Microneedle for Delivery of Water‐Insoluble Drug

Transdermal drug delivery offers advantages over nonparenteral routes such as bypassing first-pass metabolism and facile administration. Mammalian skin, however, functions

Continue reading

Recent Posts

  • Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition”
  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
  • REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition
  • Reducing Cholesterol with β-CDP: Insights for NPC and AD

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (73)
  • CD as API (355)
  • CD derivatives (431)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (816)
  • E-ducation (63)
  • Environmental (143)
  • Events (239)
  • Food (233)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (45)
  • Non-pharma applications (416)
  • Other industrial use (112)
  • Pharma applications (1,219)
  • Supramolecular systems (44)
  • Uncategorized (167)

Top Posts

  • Special Issue titled "Cyclodextrins: Properties and Applications, 4th Edition"
  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition
  • Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
  • Lanosterol eye drops for cataract treatment
  • 22nd International Cyclodextrin Symposium (ICS-22) in India
  • Cyclodextrins against skin aging
  • Amgen Submits Supplemental New Drug Application For KYPROLIS® (carfilzomib)

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...